New standard of care for lung cancer patients with EGFR mutations

Bookmark and Share
Published: 26 Jul 2019
Views: 2141
Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA

Dr Gelenis Domingo speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about the session discussing and summarising lung cancer updates from ASCO.

Dr Domingo highlights some of the abstracts and research areas she expects to be discussed, including the data supporting a new standard of care for treating lung cancer patients with epidermal growth factor receptor (EGFR) mutations.